Plasma-transforming growth factor-alpha expression in residents of an arseniasis area in Taiwan

Biomarkers

Volumn 11, Issue 6, 2006, Pages 538-546

  Hsu, K H ^a   Brandt Rauf, P ^c   Lin, T M ^f,g   Chiou, H Y ^d   Tseng, C H ^e   Chen, C J ^e   Luo, J C J ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^g YUAN ZE UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; BIOLOGICAL MARKER; DRINKING WATER; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; AGED; ARSENIC POISONING; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDEMIC DISEASE; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TAIWAN; TREND STUDY; WATER CONTAMINATION;

AGED; ARSENIC; BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; TAIWAN; TRANSFORMING GROWTH FACTOR ALPHA; WATER POLLUTANTS, CHEMICAL;

EID: 33750342069     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500600881488     Document Type: Article

References (32)

1. Ahsan, H and Perrin, M and Rahman, A and Parvez, F and Stute, M and Zheng, Y and Milton, AH and Brandt-Rauf, P and Van Geen, A and Graziano, J. (2000) Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh Journal of Occupation and Environmental Medicine, 42, pp. 1195-1201.
2. Amundadottir, LT and Nass, SJ and Berchem, GJ and Johnson, MD and Dickson, M. (1996) Cooperation of TGF-a and c-myc in mouse mammary tumorigenesis coordinated stimulation of growth and suppression of apoptosis Oncogene, 13, pp. 757-765.
3. Brandt-Rauf, P. W. (1995) The c-erbB transmembrane growth factor receptors as serum biomarkers in human cancer studies Mutation Research, 333, pp. 203-208.
4. Brissenden, JE and Deryneck, R and Francke, U. (1985) Mapping of transforming growth factor alpha gene on human chromosome 2 close to the breakpoint of the Burkitt's lymphoma t(2;8) variant translocation Cancer Research, 45, pp. 5593-5597.
5. Brown, JL and Kitchin, KT. (1996) Arsenic but not cadmium induces ornithine decarboxylase and heme oxygenase activity in rat liver, relevance to arsenic carcinogenesis Cancer Letters, 98, pp. 227-231.
6. Chen, CJ and Chen, CW and Wu, MM and Kuo, TL. (1992) Cancer potential in liver, lung, bladder, and kidney due to ingested inorganic arsenic in drinking water British Journal of Cancer, 66, pp. 888-892.
7. Chen, CJ and Chiou, HY and Chiang, MH and Lin, LJ and Tai, TY. (1996) Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arteriosclerosis Thrombosis and Vascular Biology, 16, pp. 504-510.
8. Chen, CJ and Kuo, TL and Wu, MM. (1988) Arsenic and cancers Lancet, i, pp. 414-415.
9. Chen, CJ and Hsueh, YM and Lai, MS and Shyu, MP and Chen, SY and Wu, MM and Kuo, TL and Tai, TY. (1995) Increased prevalence of hypertension and long-term arsenic exposure Hypertension, 25, pp. 53-60.
10. Chiou, HY and Hsueh, YM and Hsieh, LL and Hsu, LI and Hsu, YH and Hsieh, FI and Wei, ML and Chen, HC and Yang, HT and Leu, LC and Chu, TH and Chen-Wu, C and Yang, MH and Chen, CJ. (1997) Arsenic methylation capacity, body retention, and null genotypes of gluathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan Mutation Research, 386, pp. 197-207.
11. Do, T and Gambelunghe, A and Ahsan, H and Graziano, J and Perrin, M and Slavkovich, V and Parves, F and Milton, AH and Brandt-Rauf, P. (2001) Urinary transforming growth factor-alpha in individuals exposed to arsenic in drinking water in Bangladesh Biomarkers, 6, pp. 127-132.
12. Ellis, DL and Chow, JC and King, LE, Jr. (1990) Detection of urinary TGF-alpha by HPLC and western blot in patients with melanoma Journal of Investigative Dermatology, 95, pp. 27-30.
13. Germolec, DR and Yoshida, T and Gaido, K and Wimer, JL and Simeonova, PP and Kayama, F and Burieson, F and Dong, W and Lange, RW and Luster, MI. (1996) Arsenic induces over-expression of growth factors in human keratinocytes Toxicology and Applied Pharmacology, 141, pp. 308-318.
14. Hsu, KH and Froines, JR and Chen, CJ.(1997) Studies of arsenic ingestion from drinking-water in Northeastern Taiwan: Chemical speciation and urinary metabolites. In Arsenic exposure and health effects. (pp. 190-209). London: Chapman & Hall.
15. Hutchinson, J. (1987) Arsenic and cancer British Medical Journal, 2, pp. 1280-1281.
16. Hutchinson, J. (1988) Diseases, etc, of the skin: I. On some examples of arsenic-keratosis of the skin and of arsenic-cancer Transactions of the Pathology Society of London, 39, pp. 352-363.
17. IARC. (1980) Some metals and metallic compounds Monographs on the Evaluation of the Carcinogenesis Risk in Humans Suppl., 7, pp. 100-103.
18. Jha, AN and Noditi, M and Nilsson, R and Natarajan, AT. (1992) Genotoxic effect of sodium arsenic on human cells Mutation Research, 284, pp. 215-221.
19. Katoh, M and Inagaki, H and Kurosawa-Ohsawa, K and Katsuura, M and Tanaka, S. (1990) Detection of transformation growth factor alpha in human urine and plasma Biochemistry and Biophysics Research Communications, 167, pp. 1065-1072.
20. Lee, TC and Tanaka, N and Lamb, PW and Gimer, TM and Barrett, JC. (1988) Induction of gene amplification by arsenic Science, 241, pp. 79-81.
21. Rahman, MM and Chowdhury, UK and Mukherjee, SC and Mondal, BK and Paul, K and Lodh, D and Biswas, BK and Chanda, CR and Basu, GK and Saha, KC and Roy, S and Das, R and Palit, SK and Quamruzzaman, Q and Chakraborti, D. (2001) Chronic arsenic toxicity in Bangladesh and West Bengal India - a review and commentary Clinical Toxicology, 39, pp. 683-700.
22. Ridderheim, M and Cajander, S and Tavelin, B and Stendahl, U and Backstrom, T. (1994) EGF/TGF-alpha and progesterone in urine of ovarian cancer patients Anticancer Research, 14, pp. 2119-2123.
23. Takagi, H and Sharp, R and Takayama, H and Anver, MR and Ward, JM. (1993) Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor a of transgenic mice Cancer Research, 53, pp. 4329-4336.
24. Thorgeirsson, SS and Santoni-Rugui, E. (1996) Transgenic mouse model carcinogenesis: Interaction of c-myc with transforming growth factor a and hepatocyte growth factor in hepatocarcinogenesis British Journal of Clinical Pharmacology, 42, pp. 43-52.
25. Todare, GJ and Marquardt, H and Twardzik, DR and Reynolds, FH and Stephenson, JR.(1985) transforming growth factors produced by viral-transformed and human tumor cells. In Genes and protein in oncogenesis. (pp. 165-182). New York NY: Raven.
26. Tseng, WP and Chu, CM and How, SW and Fong, JM and Lin, CS and Yeh, S. (1968) Prevalence of skin cancer in an epidemic area of chronic arsenicism in Taiwan Journal of the National Cancer Institute, 40, pp. 453-463.
27. Vahter, M and Norin, H. (1980) Metabolism of 74 As-labeled trivalent and Pentavalent inorganic arsenic in mice Environment Research, 21, pp. 446-457.
28. Walz, TM and Malm, C and Wasteson, A. (1993) Expression of the transforming growth factor alpha protooncogene in differentiating human promyelocytic leukemia (HL-60) cells Cancer Research, 53, pp. 191-196.
29. World Health Organization (WHO). (1981) Arsenic. Environmental Health Criteria No. 18. Geneva: WHO.
30. Wu, HY and Chen, KP and Tseng, WP and Hsu, CL. (1961) Epidemiologic studies on Blackfoot disease: I. Prevalence and incidence of the disease by age, sex, occupation and geographical distribution Memoirs of the College of Medicine National Taiwan University, 7, pp. 33-50.
31. Yeh, YC and Tsai, JF and Chuang, LY and Yeh, HW and Tsai, JH and Florine, DL and Tarn, JP. (1987) Elevation of transformationing growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma Cancer Research, 47, pp. 896-901.
32. Yu, RC and Hsu, KH and Chen, CJ and Froines, JR. (2000) Arsenic methylation capacity and skin cancer Cancer Epidemiology Biomarkers and Prevention, 9, pp. 1259-1962.